Axsome Therapeutics
AXSM
AXSM
35 hedge funds and large institutions have $32.6M invested in Axsome Therapeutics in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less capital invested
Capital invested by funds: $33.3M → $32.6M (-$674K)
2.58% less ownership
Funds ownership: 25.45% → 22.88% (-2.6%)
Holders
35
Holding in Top 10
–
Calls
$207K
Puts
$85K
Top Buyers
| 1 | +$652K | |
| 2 | +$391K | |
| 3 | +$385K | |
| 4 |
Renaissance Technologies
New York
|
+$271K |
| 5 |
Goldman Sachs
New York
|
+$238K |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$1.12M | |
| 3 | -$247K | |
| 4 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$104K |
| 5 |
Barclays
London,
United Kingdom
|
-$97K |